Parenteral Nutrition–Associated Hyperglycemia in Non–Critically Ill Inpatients Increases the Risk of In-Hospital Mortality (Multicenter Study)

نویسندگان

  • Gabriel Olveira
  • María José Tapia
  • Julia Ocón
  • Carmen Cabrejas-Gómez
  • María D. Ballesteros-Pomar
  • Alfonso Vidal-Casariego
  • Carmen Arraiza-Irigoyen
  • Josefina Olivares
  • Maria del Carmen Conde-García
  • Álvaro García-Manzanares
  • Francisco Botella-Romero
  • Rosa P. Quílez-Toboso
  • Lucio Cabrerizo
  • Pilar Matia
  • Luisa Chicharro
  • Rosa Burgos
  • Pedro Pujante
  • Mercedes Ferrer
  • Ana Zugasti
  • Javier Prieto
  • Marta Diéguez
  • María José Carrera
  • Anna Vila-Bundo
  • Juan Ramón Urgelés
  • Carmen Aragón-Valera
  • Adela Rovira
  • Irene Bretón
  • Pilar García-Peris
  • Araceli Muñoz-Garach
  • Efren Márquez
  • Dolores del Olmo
  • José Luis Pereira
  • María C. Tous
چکیده

OBJECTIVE Hyperglycemia may increase mortality in patients who receive total parenteral nutrition (TPN). However, this has not been well studied in noncritically ill patients (i.e., patients in the nonintensive care unit setting). The aim of this study was to determine whether mean blood glucose level during TPN infusion is associated with increased mortality in noncritically ill hospitalized patients. RESEARCH DESIGN AND METHODS This prospective multicenter study involved 19 Spanish hospitals. Noncritically ill patients who were prescribed TPN were included prospectively, and data were collected on demographic, clinical, and laboratory variables as well as on in-hospital mortality. RESULTS The study included 605 patients (mean age 63.2 ± 15.7 years). The daily mean TPN values were 1.630 ± 323 kcal, 3.2 ± 0.7 g carbohydrates/kg, 1.26 ± 0.3 g amino acids/kg, and 0.9 ± 0.2 g lipids/kg. Multiple logistic regression analysis showed that the patients who had mean blood glucose levels >180 mg/dL during the TPN infusion had a risk of mortality that was 5.6 times greater than those with mean blood glucose levels <140 mg/dL (95% CI 1.47-21.4 mg/dL) after adjusting for age, sex, nutritional state, presence of diabetes or hyperglycemia before starting TPN, diagnosis, prior comorbidity, carbohydrates infused, use of steroid therapy, SD of blood glucose level, insulin units supplied, infectious complications, albumin, C-reactive protein, and HbA1c levels. CONCLUSIONS Hyperglycemia (mean blood glucose level >180 mg/dL) in noncritically ill patients who receive TPN is associated with a higher risk of in-hospital mortality.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Parenteral Nutrition-Associated Hyperglycemia in Noncritically Ill Inpatients Increases the Risk of In- hospital Mortality (Multicenter Study) Study Group of Hyperglycemia in Parenteral Nutrition: Nutrition Area of the Spanish Society of Endocrinology and Nutrition (SEEN)

GABRIEL OLVEIRA, PHD MAR IA JOSÉ TAPIA, MD JULIA OCÓN, PHD CARMEN CABREJAS-GÓMEZ, MD MAR IA D. BALLESTEROS-POMAR, PHD ALFONSO VIDAL-CASARIEGO, MD CARMEN ARRAIZA-IRIGOYEN, MD JOSEFINA OLIVARES, MD MARIA DEL CARMEN CONDE-GARC IA, PHD ALVARO GARC IA-MANZANARES, MD FRANCISCO BOTELLA-ROMERO, PHD ROSA P. QU ILEZ-TOBOSO, MD LUCIO CABRERIZO, PHD PILAR MATIA, MD LUISA CHICHARRO, MD ROSA BURGOS, PHD PEDR...

متن کامل

Metformin Treatment in Hyperglycemic Critically Ill Patients: Another Challenge on the Control of Adverse Outcomes

New-onset hyperglycemia in patients admitted to intensive care units increases the risk of morbidity and mortality. Insulin resistance is frequently seen in the treatment of stress-induced hyperglycemia. Metformin, an oral anti-hyperglycemic agent, may introduce a new treatment protocol in critically ill patients with insulin-resistance hyperglycemia. Fifty-one non-diabetic traumatized patients...

متن کامل

Metformin Treatment in Hyperglycemic Critically Ill Patients: Another Challenge on the Control of Adverse Outcomes

New-onset hyperglycemia in patients admitted to intensive care units increases the risk of morbidity and mortality. Insulin resistance is frequently seen in the treatment of stress-induced hyperglycemia. Metformin, an oral anti-hyperglycemic agent, may introduce a new treatment protocol in critically ill patients with insulin-resistance hyperglycemia. Fifty-one non-diabetic traumatized patients...

متن کامل

Higher dextrose delivery via TPN related to the development of hyperglycemia in non-diabetic critically ill patients

The beneficial effects of total parenteral nutrition (TPN) in improving the nutritional status of malnourished patients during hospital stays have been well established. However, recent randomized trials and meta-analyses have reported an increased rate of TPN-associated complications and mortality in critically ill patients. The increased risk of complications during TPN therapy has been linke...

متن کامل

Study of hyperglycemia in non critically-ill patients receiving parenteral nutrition: incidence and risk factors.

BACKGROUND The objectives of our study on non-critically ill patients receiving parenteral nutrition (PN) are to assess the incidence of hyperglycemia, the risk factors associated to its development and its influence in patient's evolution. METHODS A multicentric prospective observational study was performed in 9 hospitals. Four multivariate studies were developed to study the temporal risk i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 36  شماره 

صفحات  -

تاریخ انتشار 2013